Been sitting on this one for a while but I've noticed no one commented on the half-yearly presentation, and no one's really raised this point on 4DX's growth in fee per scan: This was slide 7 and demonstrates how much impact the US market and reimbursement will have on their revenue. Whilst their tech was mostly being rolled out in AUS, the average fee per scan was quite pitiful. If Phillips is assisting with our market penetration and uptake in the US, we should see this average get gradually closer to the US $650 reimbursement figure over time. Based on this I'm cautiously hopeful that our next quarter's sales will be more promising towards cash runway stability.
As there were no comments on this when it was released, interested to hear thoughts.
4DX Price at posting:
26.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)